Quick Answer
ROCKWELL MEDICAL, INC. reported R&D Expense of $0.00 for fiscal year 2025.
ROCKWELL MEDICAL, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $19.0K | -98.3% |
| 2023 | $1.11M | -80.4% |
| 2018 | $5.64M | -10.7% |
| 2017 | $6.32M | +8.2% |
| 2016 | $5.84M | +17.7% |
| 2015 | $4.96M | -36.3% |
| 2014 | $7.78M | -80.2% |
| 2013 | $39.38M | -18.4% |
| 2012 | $48.27M | +171.1% |
| 2011 | $17.81M | +420.3% |
| 2010 | $3.42M | -47.0% |
| 2009 | $6.45M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | -100.0% | — |
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | -100.0% |
| March 31, 2024 | $18.0K | -93.5% | -96.4% |
| September 30, 2023 | $494.0K | +5.3% | +195.8% |
| June 30, 2023 | $167.0K | -82.0% | -39.9% |
- ROCKWELL MEDICAL, INC. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, ROCKWELL MEDICAL, INC.’s r&d expense has declined by 100.0% (from $6.45 million to $0.00).
- The most recent figure is from ROCKWELL MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: